Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company's product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:UTMD
- CUSIP: 91748810
- Web: www.utahmed.com
- Market Cap: $274.09 million
- Outstanding Shares: 3,719,000
- 50 Day Moving Avg: $71.84
- 200 Day Moving Avg: $67.45
- 52 Week Range: $56.30 - $75.00
Sales & Book Value:
- Trailing P/E Ratio: 20.59
- Foreward P/E Ratio: 24.73
- P/E Growth: 0.00
- Annual Revenue: $39.6 million
- Price / Sales: 6.92
- Book Value: $20.78 per share
- Price / Book: 3.55
- Annual Dividend: $1.06
- Dividend Yield: 1.5%
- EBIDTA: $20.09 million
- Net Margins: 32.98%
- Return on Equity: 17.91%
- Return on Assets: 15.95%
- Current Ratio: 9.97%
- Quick Ratio: 8.88%
- Average Volume: 12,511 shs.
- Beta: 0.74
- Short Ratio: 2.2
Frequently Asked Questions for Utah Medical Products (NASDAQ:UTMD)
What is Utah Medical Products' stock symbol?
Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."
How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?
Utah Medical Products declared a quarterly dividend on Thursday, August 3rd. Stockholders of record on Friday, September 15th will be paid a dividend of $0.265 per share on Tuesday, October 3rd. This represents a $1.06 annualized dividend and a dividend yield of 1.44%. The ex-dividend date is Thursday, September 14th. View Utah Medical Products' Dividend History.
How were Utah Medical Products' earnings last quarter?
Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings results on Tuesday, April, 25th. The company reported $0.95 earnings per share (EPS) for the quarter. The business earned $10.26 million during the quarter. Utah Medical Products had a return on equity of 17.91% and a net margin of 32.98%. View Utah Medical Products' Earnings History.
When will Utah Medical Products make its next earnings announcement?
Who are some of Utah Medical Products' key competitors?
Some companies that are related to Utah Medical Products include Invacare Corporation (IVC), Consort Medical plc (CSRT), Antares Pharma (ATRS), Exactech (EXAC), STAAR Surgical Company (STAA), Sientra (SIEN), Transenterix (TRXC), Transenterix (TRXC), Ocular Therapeutix (OCUL), T2 Biosystems (TTOO), SeaSpine Holdings Corporation (SPNE), Bioquell plc (BQE), Tandem Diabetes Care (TNDM), Capnia (SLNO), Alliqua BioMedical (ALQA), Surgical Innovations Group Plc (SUN), Cytori Therapeutics (CYTX) and Lombard Medical (EVAR).
Who are Utah Medical Products' key executives?
Utah Medical Products' management team includes the folowing people:
- Kevin L. Cornwell, Chairman of the Board, President, Chief Executive Officer and Secretary
- Paul O. Richins, Principal Financial Officer, Chief Administrative Officer, Vice President, Treasurer, Assistant Secretary, Director
- Ernst G. Hoyer, Lead Independent Director
- James H. Beeson M.D. Ph.D., Independent Director
- Barbara A. Payne Ph.D., Independent Director
Who owns Utah Medical Products stock?
Utah Medical Products' stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (13.24%), Renaissance Technologies LLC (4.48%), American Century Companies Inc. (4.32%), Dimensional Fund Advisors LP (4.30%), Vanguard Group Inc. (3.55%) and WCM Investment Management CA (2.20%). Company insiders that own Utah Medical Products stock include Ernst G Hoyer, Kevin L Cornwell and Paul O Richins. View Institutional Ownership Trends for Utah Medical Products.
Who sold Utah Medical Products stock? Who is selling Utah Medical Products stock?
Utah Medical Products' stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., JPMorgan Chase & Co., Bank of New York Mellon Corp, Schwab Charles Investment Management Inc., California State Teachers Retirement System, Morgan Dempsey Capital Management LLC, Sei Investments Co. and TIAA CREF Investment Management LLC. Company insiders that have sold Utah Medical Products stock in the last year include Ernst G Hoyer and Kevin L Cornwell. View Insider Buying and Selling for Utah Medical Products.
Who bought Utah Medical Products stock? Who is buying Utah Medical Products stock?
Utah Medical Products' stock was purchased by a variety of institutional investors in the last quarter, including Brandes Investment Partners LP, Renaissance Technologies LLC, FMR LLC, Russell Investments Group Ltd., State Street Corp, Dimensional Fund Advisors LP, Spark Investment Management LLC and OxFORD Asset Management LLP. View Insider Buying and Selling for Utah Medical Products.
How do I buy Utah Medical Products stock?
Shares of Utah Medical Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Utah Medical Products' stock price today?
MarketBeat Community Rating for Utah Medical Products (NASDAQ UTMD)MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Utah Medical Products stock can currently be purchased for approximately $73.70.
Consensus Ratings for Utah Medical Products (NASDAQ:UTMD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Utah Medical Products (NASDAQ:UTMD)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Utah Medical Products (NASDAQ:UTMD)Earnings History by Quarter for Utah Medical Products (NASDAQ UTMD)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/25/2017||Q1 2017||$0.95||$10.26 million||View||N/A|
|2/2/2016||Q415||$0.85||$10.20 million||$9.58 million||View||N/A|
|7/24/2014||Q214||$0.69||$0.75||$10.00 million||$10.49 million||View||N/A|
|1/30/2014||Q413||$0.64||$0.91||$9.83 million||$10.09 million||View||N/A|
|7/25/2013||Q2 2013||$0.62||$0.70||$10.03 million||$10.00 million||View||N/A|
|4/25/2013||Q113||$0.73||$11.21 million||$10.37 million||View||N/A|
|1/31/2013||Q4 2012||$0.60||$9.90 million||$9.80 million||View||N/A|
Earnings Estimates for Utah Medical Products (NASDAQ:UTMD)
Current Year EPS Consensus Estimate: $2.81 EPS
Next Year EPS Consensus Estimate: $2.98 EPS
Current Dividend Information for Utah Medical Products (NASDAQ:UTMD)
|Payout Ratio:||30.37% (Trailing 12 Months of Earnings) |
37.72% (Based on This Year's Estimates)
35.57% (Based on Next Year's Estimates)
Dividend History by Quarter for Utah Medical Products (NASDAQ UTMD)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Utah Medical Products (NASDAQ:UTMD)
Insider Ownership Percentage: 9.10%Insider Trades by Quarter for Utah Medical Products (NASDAQ:UTMD)
Institutional Ownership Percentage: 66.77%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/12/2016||Kevin L Cornwell||CEO||Sell||3,531||$69.25||$244,521.75|| |
|12/8/2016||Kevin L Cornwell||CEO||Sell||5,286||$70.10||$370,548.60|| |
|11/30/2016||Kevin L Cornwell||CEO||Sell||3,183||$69.03||$219,722.49|| |
|11/29/2016||Kevin L Cornwell||CEO||Sell||664||$69.00||$45,816.00|| |
|11/28/2016||Kevin L Cornwell||CEO||Sell||1,906||$69.05||$131,609.30|| |
|11/21/2016||Ernst G Hoyer||Director||Sell||362||$66.28||$23,993.36|| |
|11/17/2016||Ernst G Hoyer||Director||Sell||3,894||$66.30||$258,172.20|| |
|9/13/2016||Kevin L Cornwell||CEO||Sell||1,396||$63.09||$88,073.64|| |
|9/8/2016||Ernst G Hoyer||Director||Sell||63||$63.81||$4,020.03|| |
|9/7/2016||Kevin L Cornwell||CEO||Sell||408||$64.06||$26,136.48|| |
|8/31/2016||Kevin L Cornwell||CEO||Sell||716||$64.04||$45,852.64|| |
|8/29/2016||Kevin L Cornwell||CEO||Sell||2,200||$64.71||$142,362.00|| |
|8/15/2016||Kevin L Cornwell||CEO||Sell||23||$64.00||$1,472.00|| |
|8/10/2016||Kevin L Cornwell||CEO||Sell||1,800||$64.13||$115,434.00|| |
|5/31/2016||Paul O Richins||VP||Sell||396||$64.50||$25,542.00|| |
|5/27/2016||Paul O Richins||VP||Sell||271||$65.28||$17,690.88|| |
|11/10/2014||Kevin L Cornwell||CEO||Sell||3,472||$58.50||$203,112.00|| |
|3/14/2014||Ernst G Hoyer||Director||Sell||1,486||$56.04||$83,275.44|| |
|3/10/2014||Kevin L Cornwell||CEO||Sell||2,497||$55.45||$138,458.65|| |
|3/6/2014||Kevin L Cornwell||CEO||Sell||2,684||$55.69||$149,471.96|| |
|2/28/2014||Kevin L Cornwell||CEO||Sell||1,341||$55.48||$74,398.68|| |
|12/9/2013||Kevin L Cornwell||CEO||Sell||1,885||$51.65||$97,360.25|| |
|12/5/2013||Kevin L Cornwell||CEO||Sell||1,402||$51.55||$72,273.10|| |
|11/22/2013||Kevin L Cornwell||CEO||Sell||3,455||$53.13||$183,564.15|| |
|10/30/2013||Kevin L Cornwell||CEO||Sell||1,915||$56.40||$108,006.00|| |
|9/12/2013||Kevin L Cornwell||CEO||Sell||4,636||$50.50||$234,118.00|| |
|8/30/2013||Ernst G Hoyer||Director||Sell||10,000||$50.72||$507,200.00|| |
|8/23/2013||Kevin L Cornwell||CEO||Sell||5,715||$50.31||$287,521.65|| |
|7/31/2013||Kevin L Cornwell||CEO||Sell||8,100||$57.65||$466,965.00|| |
Headline Trends for Utah Medical Products (NASDAQ:UTMD)
Latest Headlines for Utah Medical Products (NASDAQ:UTMD)
|Utah Medical Products goes ex-dividend tomorrow|
seekingalpha.com - September 13 at 10:50 AM
|Head-To-Head Comparison: Lombard Medical (EVAR) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - September 8 at 4:14 PM
|3 Top Small-Cap Blend Mutual Funds for Attractive Returns|
www.zacks.com - August 29 at 9:21 AM
|Utah Medical Products (UTMD) vs. Landauer (LDR) Financial Comparison|
www.americanbankingnews.com - August 27 at 10:24 PM
|Zacks: Utah Medical Products, Inc. (UTMD) Given Average Rating of "" by Brokerages|
www.americanbankingnews.com - August 20 at 6:38 PM
|Utah Medical Products (UTMD) vs. Antares Pharma (ATRS) Head-To-Head Survey|
www.americanbankingnews.com - August 15 at 2:20 AM
|Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017|
finance.yahoo.com - August 5 at 8:14 AM
|Utah Medical Products, Inc. Declares Quarterly Dividend of $0.27 (UTMD)|
www.americanbankingnews.com - August 4 at 2:22 PM
|Utah Medical Products, Inc. (NASDAQ:UTMD) Downgraded by BidaskClub|
www.americanbankingnews.com - August 3 at 1:12 PM
|Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017|
finance.yahoo.com - July 26 at 9:34 AM
|Utah Medical Products reports Q2 results|
seekingalpha.com - July 26 at 5:13 AM
|BidaskClub Downgrades Utah Medical Products, Inc. (NASDAQ:UTMD) to Buy|
www.americanbankingnews.com - July 25 at 2:45 PM
|Utah Medical Products, Inc. (UTMD) Set to Announce Earnings on Monday|
www.americanbankingnews.com - July 22 at 10:23 AM
|Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : June 16th, 2017 (record date) : By the numbers : June 16, 2017|
finance.yahoo.com - June 17 at 7:00 AM
|Cash Dividend On The Way From Utah Medical Products (UTMD)|
www.thestreet.com - June 12 at 7:56 PM
|ValuEngine Upgrades Utah Medical Products, Inc. (UTMD) to Hold|
www.americanbankingnews.com - June 6 at 7:22 PM
|ETFs with exposure to Utah Medical Products, Inc. : June 2, 2017|
finance.yahoo.com - June 2 at 3:58 PM
|Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q1, 2017 By the Numbers : June 1, 2017|
finance.yahoo.com - June 2 at 3:15 AM
|Utah Medical Products, Inc. Plans Quarterly Dividend of $0.27 (UTMD)|
www.americanbankingnews.com - May 11 at 7:34 PM
|Utah Medical Products (UTMD) Getting Somewhat Favorable Media Coverage, Analysis Finds|
www.americanbankingnews.com - May 1 at 7:12 PM
|Utah Medical Products, Inc. (UTMD) Announces Earnings Results|
www.americanbankingnews.com - April 26 at 2:46 PM
|Utah Medical Products (UTMD) Getting Positive Media Coverage, Study Finds|
www.americanbankingnews.com - April 26 at 10:22 AM
|Utah Medical posts 1Q profit|
marketbeat.com - April 25 at 9:26 AM
|Utah Medical Products (UTMD) Earns Daily Media Impact Score of -0.35|
www.americanbankingnews.com - April 21 at 7:47 AM
|Utah Medical Products (UTMD) Given News Sentiment Score of 0.24|
www.americanbankingnews.com - April 16 at 9:50 AM
|Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : March 17th, 2017 (record date) : By the numbers : April 6, 2017|
finance.yahoo.com - April 7 at 1:19 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 10-K, Annual Report|
biz.yahoo.com - March 9 at 4:04 AM
|BRIEF-Utah Medical Products Inc Q4 earnings per share of $0.725|
www.reuters.com - February 1 at 7:16 AM
|Utah Medical Products (UTMD) Declares $0.265 Quarterly Dividend; 1.7% Yield|
www.streetinsider.com - November 1 at 8:19 PM
|Utah Medical Products declares $0.265 dividend|
seekingalpha.com - November 1 at 8:19 PM
|BRIEF-Utah Medical Products Inc increases quarterly dividend by 2 pct to $0.265 per share|
www.reuters.com - November 1 at 8:19 PM
|Utah Medical Products goes ex-dividend today|
seekingalpha.com - September 15 at 11:40 AM
|Utah Medical reports Q4 and FY15 results|
seekingalpha.com - February 2 at 2:28 PM
|Utah Medical Products Reports Audited Financial Performance for Fourth Quarter and Year 2015|
finance.yahoo.com - February 2 at 9:00 AM
|Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023|
www.prnewswire.com - January 28 at 2:06 PM
|UTAH MEDICAL PRODUCTS INC Financials|
finance.yahoo.com - December 8 at 1:17 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - November 6 at 3:38 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Other Events|
biz.yahoo.com - November 3 at 12:40 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition|
biz.yahoo.com - October 22 at 1:39 PM
|Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2015|
finance.yahoo.com - October 22 at 9:00 AM
Utah Medical Products (UTMD) Chart for Friday, September, 22, 2017